Report Detail

Other Global Hadron Therapy Market Professional Survey Report 2019

  • RnM3796830
  • |
  • 01 October, 2019
  • |
  • Global
  • |
  • 105 Pages
  • |
  • QYResearch
  • |
  • Other

Radiation therapy is the medical use of ionizing radiation to treat cancer. In conventional radiation therapy, beams of X rays (high energy photons) are produced by accelerated electrons and then delivered to the patient to destroy tumour cells. Using crossing beams from many angles, radiation oncologists irradiate the tumour target while trying to spare the surrounding normal tissues. Inevitably some radiation dose is always deposited in the healthy tissues.
When the irradiating beams are made of charged particles (protons and other ions, such as carbon), radiation therapy is called hadrontherapy. The strength of hadrontherapy lies in the unique physical and radiobiological properties of these particles; they can penetrate the tissues with little diffusion and deposit the maximum energy just before stopping. This allows a precise definition of the specific region to be irradiated. The peaked shape of the hadron energy deposition is called Bragg peak and has become the symbol of hadrontherapy. With the use of hadrons the tumour can be irradiated while the damage to healthy tissues is less than with X-rays.
The idea of using protons for cancer treatment was first proposed in 1946 by the physicist Robert Wilson, who later became the founder and first director of the Fermi National Accelerator Laboratory (Fermilab) near Chicago. The first patients were treated in the 1950s in nuclear physics research facilities by means of non-dedicated accelerators. Initially, the clinical applications were limited to few parts of the body, as accelerators were not powerful enough to allow protons to penetrate deep in the tissues.
In the late 1970s improvements in accelerator technology, coupled with advances in medical imaging and computing, made proton therapy a viable option for routine medical applications. However, it has only been since the beginning of the 1990s that proton facilities have been established in clinical settings, the first one being in Loma Linda, USA. Currrently about thirty proton centres are either in operation or in construction worldwide.

The global Hadron Therapy market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Hadron Therapy volume and value at global level, regional level and company level. From a global perspective, this report represents overall Hadron Therapy market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Hadron Therapy in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Hadron Therapy manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Koninklijke Philips N.V.
Advanced Oncotherapy
Varian Medical Systems
Optivus Proton Therapy
Hitachi, Ltd.
Mevion Medical Systems
ProTom International
Mitsubishi Electric Corporation
Sumitomo Corporation
ProNova Solutions, LLC

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Electron Beam
Proton Beam
Neutron Beam
Carbon Ion Beam
Alpha Particle Beam
Beta Particle Beam

Segment by Application
Pediatric Cancer
Bone and Soft Tissue Cancer
Prostate Cancer
Lung Cancer
Liver Cancer
Eye Cancer
Head & Neck Cancer
Others Applications (Renal Cell Carcinoma, Cervical, Gastric, and Lymphoma)


Table of Contents

    Executive Summary

      1 Industry Overview of Hadron Therapy

      • 1.1 Definition of Hadron Therapy
      • 1.2 Hadron Therapy Segment by Type
        • 1.2.1 Global Hadron Therapy Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Electron Beam
        • 1.2.3 Proton Beam
        • 1.2.4 Neutron Beam
        • 1.2.5 Carbon Ion Beam
        • 1.2.6 Alpha Particle Beam
        • 1.2.7 Beta Particle Beam
      • 1.3 Hadron Therapy Segment by Applications
        • 1.3.1 Global Hadron Therapy Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Pediatric Cancer
        • 1.3.3 Bone and Soft Tissue Cancer
        • 1.3.4 Prostate Cancer
        • 1.3.5 Lung Cancer
        • 1.3.6 Liver Cancer
        • 1.3.7 Eye Cancer
        • 1.3.8 Head & Neck Cancer
        • 1.3.9 Others Applications (Renal Cell Carcinoma, Cervical, Gastric, and Lymphoma)
      • 1.4 Global Hadron Therapy Overall Market
        • 1.4.1 Global Hadron Therapy Revenue (2014-2025)
        • 1.4.2 Global Hadron Therapy Production (2014-2025)
        • 1.4.3 North America Hadron Therapy Status and Prospect (2014-2025)
        • 1.4.4 Europe Hadron Therapy Status and Prospect (2014-2025)
        • 1.4.5 China Hadron Therapy Status and Prospect (2014-2025)
        • 1.4.6 Japan Hadron Therapy Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Hadron Therapy Status and Prospect (2014-2025)
        • 1.4.8 India Hadron Therapy Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Hadron Therapy
      • 2.3 Manufacturing Process Analysis of Hadron Therapy
      • 2.4 Industry Chain Structure of Hadron Therapy

      3 Development and Manufacturing Plants Analysis of Hadron Therapy

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Hadron Therapy Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Hadron Therapy
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Hadron Therapy Production and Capacity Analysis
      • 4.2 Hadron Therapy Revenue Analysis
      • 4.3 Hadron Therapy Price Analysis
      • 4.4 Market Concentration Degree

      5 Hadron Therapy Regional Market Analysis

      • 5.1 Hadron Therapy Production by Regions
        • 5.1.1 Global Hadron Therapy Production by Regions
        • 5.1.2 Global Hadron Therapy Revenue by Regions
      • 5.2 Hadron Therapy Consumption by Regions
      • 5.3 North America Hadron Therapy Market Analysis
        • 5.3.1 North America Hadron Therapy Production
        • 5.3.2 North America Hadron Therapy Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Hadron Therapy Import and Export
      • 5.4 Europe Hadron Therapy Market Analysis
        • 5.4.1 Europe Hadron Therapy Production
        • 5.4.2 Europe Hadron Therapy Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Hadron Therapy Import and Export
      • 5.5 China Hadron Therapy Market Analysis
        • 5.5.1 China Hadron Therapy Production
        • 5.5.2 China Hadron Therapy Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Hadron Therapy Import and Export
      • 5.6 Japan Hadron Therapy Market Analysis
        • 5.6.1 Japan Hadron Therapy Production
        • 5.6.2 Japan Hadron Therapy Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Hadron Therapy Import and Export
      • 5.7 Southeast Asia Hadron Therapy Market Analysis
        • 5.7.1 Southeast Asia Hadron Therapy Production
        • 5.7.2 Southeast Asia Hadron Therapy Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Hadron Therapy Import and Export
      • 5.8 India Hadron Therapy Market Analysis
        • 5.8.1 India Hadron Therapy Production
        • 5.8.2 India Hadron Therapy Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Hadron Therapy Import and Export

      6 Hadron Therapy Segment Market Analysis (by Type)

      • 6.1 Global Hadron Therapy Production by Type
      • 6.2 Global Hadron Therapy Revenue by Type
      • 6.3 Hadron Therapy Price by Type

      7 Hadron Therapy Segment Market Analysis (by Application)

      • 7.1 Global Hadron Therapy Consumption by Application
      • 7.2 Global Hadron Therapy Consumption Market Share by Application (2014-2019)

      8 Hadron Therapy Major Manufacturers Analysis

      • 8.1 Koninklijke Philips N.V.
        • 8.1.1 Koninklijke Philips N.V. Hadron Therapy Production Sites and Area Served
        • 8.1.2 Koninklijke Philips N.V. Product Introduction, Application and Specification
        • 8.1.3 Koninklijke Philips N.V. Hadron Therapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Advanced Oncotherapy
        • 8.2.1 Advanced Oncotherapy Hadron Therapy Production Sites and Area Served
        • 8.2.2 Advanced Oncotherapy Product Introduction, Application and Specification
        • 8.2.3 Advanced Oncotherapy Hadron Therapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Varian Medical Systems
        • 8.3.1 Varian Medical Systems Hadron Therapy Production Sites and Area Served
        • 8.3.2 Varian Medical Systems Product Introduction, Application and Specification
        • 8.3.3 Varian Medical Systems Hadron Therapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Optivus Proton Therapy
        • 8.4.1 Optivus Proton Therapy Hadron Therapy Production Sites and Area Served
        • 8.4.2 Optivus Proton Therapy Product Introduction, Application and Specification
        • 8.4.3 Optivus Proton Therapy Hadron Therapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Hitachi, Ltd.
        • 8.5.1 Hitachi, Ltd. Hadron Therapy Production Sites and Area Served
        • 8.5.2 Hitachi, Ltd. Product Introduction, Application and Specification
        • 8.5.3 Hitachi, Ltd. Hadron Therapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Mevion Medical Systems
        • 8.6.1 Mevion Medical Systems Hadron Therapy Production Sites and Area Served
        • 8.6.2 Mevion Medical Systems Product Introduction, Application and Specification
        • 8.6.3 Mevion Medical Systems Hadron Therapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 ProTom International
        • 8.7.1 ProTom International Hadron Therapy Production Sites and Area Served
        • 8.7.2 ProTom International Product Introduction, Application and Specification
        • 8.7.3 ProTom International Hadron Therapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Mitsubishi Electric Corporation
        • 8.8.1 Mitsubishi Electric Corporation Hadron Therapy Production Sites and Area Served
        • 8.8.2 Mitsubishi Electric Corporation Product Introduction, Application and Specification
        • 8.8.3 Mitsubishi Electric Corporation Hadron Therapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Sumitomo Corporation
        • 8.9.1 Sumitomo Corporation Hadron Therapy Production Sites and Area Served
        • 8.9.2 Sumitomo Corporation Product Introduction, Application and Specification
        • 8.9.3 Sumitomo Corporation Hadron Therapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 ProNova Solutions, LLC
        • 8.10.1 ProNova Solutions, LLC Hadron Therapy Production Sites and Area Served
        • 8.10.2 ProNova Solutions, LLC Product Introduction, Application and Specification
        • 8.10.3 ProNova Solutions, LLC Hadron Therapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served

      9 Development Trend of Analysis of Hadron Therapy Market

      • 9.1 Global Hadron Therapy Market Trend Analysis
        • 9.1.1 Global Hadron Therapy Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Hadron Therapy Regional Market Trend
        • 9.2.1 North America Hadron Therapy Forecast 2019-2025
        • 9.2.2 Europe Hadron Therapy Forecast 2019-2025
        • 9.2.3 China Hadron Therapy Forecast 2019-2025
        • 9.2.4 Japan Hadron Therapy Forecast 2019-2025
        • 9.2.5 Southeast Asia Hadron Therapy Forecast 2019-2025
        • 9.2.6 India Hadron Therapy Forecast 2019-2025
      • 9.3 Hadron Therapy Market Trend (Product Type)
      • 9.4 Hadron Therapy Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Hadron Therapy Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Summary:
        Get latest Market Research Reports on Hadron Therapy. Industry analysis & Market Report on Hadron Therapy is a syndicated market report, published as Global Hadron Therapy Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Hadron Therapy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $3,500.00
        $5,250.00
        $7,000.00
        2,768.50
        4,152.75
        5,537.00
        3,227.00
        4,840.50
        6,454.00
        543,550.00
        815,325.00
        1,087,100.00
        292,250.00
        438,375.00
        584,500.00
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report